NASDAQ : CASI

CASI Pharmaceuticals, Inc. — Institutional Ownership

$0.1505 USD

$0.0 (3.08%)

Volume
7.9K
Average Volume
225.2K
Market Capitalization
$2.33M
P/E Ratio
-0.07
Dividend Yield
0.00%
Price Target
$6.00
Year High
$3.09
Year Low
$0.14
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.30
Institutional Ownership Summary
Institutional Ownership %

%

Investors Holding

change: 0.0 | last:
Increased Positions

change: 0.0 | last:
Reduced Positions

change: 0.0 | last:
New Positions

change: 0.0 | last:
Sold Positions

change: 0.0 | last:
Total Calls

-

Total Puts

-

Put-Call Ratio

change: 0.0 | last:
Total Invested

-

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2026-05-18 WEI-WU HE, Ph.D. 23.99M 58.80%
2026-03-23 ETP Global III Fund L.P. 15M 42.20%
2026-03-23 HE Family GRAT 100000.0 0.50%
2026-03-23 ETP BIOHEALTH III FUND, L.P. 300K 1.50%
2026-03-23 ETP Global Fund L.P. 753.23K 3.70%
2026-03-23 EMERGING TECHNOLOGY PARTNERS, LLC 16.1M 45.30%
2026-03-23 HUIYING MEMORIAL FOUNDATION 637.64K 3.10%
2026-03-23 WEI-WU HE, Ph.D. 18.99M 53.00%
2026-02-17 Venrock Healthcare Capital Partners III, L.P. 1.99M 9.20%
2026-02-13 Foresite Capital Fund VI LP - 0.00%
2026-02-10 HE Family GRAT 100000.0 0.50%
2026-02-10 WEI-WU HE, Ph.D. 13.97M 45.40%
2026-02-10 HUIYING MEMORIAL FOUNDATION 637.64K 3.10%
2026-02-10 EMERGING TECHNOLOGY PARTNERS, LLC 1.1M 5.30%
2026-02-10 ETP Global Fund L.P. 753.23K 3.70%
2026-02-10 ETP BIOHEALTH III FUND, L.P. 300K 1.50%
2026-02-10 ETP Global Fund III L.P. 10M 32.70%
2026-01-29 WEI-WU HE, Ph.D. 8.97M 34.80%
2026-01-29 ETP Global Fund III L.P. 5M 19.60%
2026-01-29 HE Family GRAT 100000.0 0.50%
2026-01-29 ETP BIOHEALTH III FUND, L.P. 300K 1.50%
2026-01-29 ETP Global Fund L.P. 753.23K 3.70%
2026-01-29 EMERGING TECHNOLOGY PARTNERS, LLC 1.1M 5.30%
2026-01-29 HUIYING MEMORIAL FOUNDATION 637.64K 3.10%
2026-01-20 TIANJIN JINGRAN MANAGEMENT CENTER (LIMITED PARTNERSHIP) 1.02M 5.00%
2026-01-20 SNOW MOON LTD 1.02M 5.00%
2026-01-20 SPARKLE BYTE LTD 1.02M 5.00%
2026-01-20 Zhou Quan 992.64K 4.80%
2026-01-20 Ho Chi Sing 915.85K 4.50%
2026-01-20 IDG-Accel China Growth Fund GP III Associates Ltd. 915.85K 4.50%
2026-01-20 IDG-Accel China Growth Fund III Associates L.P. 915.85K 4.50%
2026-01-20 IDG-Accel China III Investors L.P. 915.85K 4.50%
2026-01-20 IDG-Accel China Growth Fund III L.P. 915.85K 4.50%
2026-01-20 Xizang Hexie Enterprise Management Co., Ltd. 1.02M 5.00%
2026-01-20 Zhuhai Hexie Zhiyuan Management Consulting Co., Ltd. 1.02M 5.00%
2026-01-20 Jianguang Li 1.02M 5.00%
2026-01-20 Dongliang Lin 1.02M 5.00%
2026-01-20 Jingbo Wang 1.02M 5.00%
2026-01-20 Kuiguang Niu 1.02M 5.00%
2026-01-20 Beijing Hexie Kangjian Investment Center (Limited Partnership) 1.02M 5.00%
2026-01-20 Beijing Hexie Tiancheng Investment Management Center (Limited Partnership) 1.02M 5.00%
2026-01-20 He Xie Ai Qi Investment Management (Beijing) Co., Ltd. 1.02M 5.00%
2026-01-09 HE Family GRAT 100000.0 0.50%
2026-01-09 ETP BIOHEALTH III FUND, L.P. 300K 1.50%
2026-01-09 ETP Global Fund L.P. 753.23K 3.70%
2026-01-09 EMERGING TECHNOLOGY PARTNERS, LLC 1.1M 5.30%
2026-01-09 HUIYING MEMORIAL FOUNDATION 637.64K 3.10%
2026-01-09 WEI-WU HE, Ph.D. 3.97M 19.10%
2025-12-18 ETP Global Fund L.P. 753.23K 3.70%
2025-12-18 HUIYING MEMORIAL FOUNDATION 637.64K 3.10%
2025-12-18 WEI-WU HE, Ph.D. 3.97M 19.10%
2025-12-18 HE Family GRAT 100000.0 0.50%
2025-12-18 ETP BIOHEALTH III FUND, L.P. 300K 1.50%
2025-12-18 EMERGING TECHNOLOGY PARTNERS, LLC 1.1M 5.30%
2025-12-17 Panacea Venture Healthcare Fund II GP Company, Ltd. 4.53M 22.00%
2025-12-17 Panacea Venture Healthcare Fund II, L.P. 4.53M 22.00%
2025-12-17 Panacea Innovation Limited 4.53M 22.00%
2025-12-17 James Huang 4.65M 22.50%
2025-11-26 Chen Zhenfeng 2.26M 11.00%
2025-11-14 Foresite Capital Fund VI LP 979.96K 6.30%
2025-09-26 Panacea Venture Healthcare Fund II GP Company, Ltd. 3.55M 19.40%
2025-09-26 James Huang 3.66M 19.90%
2025-09-26 Panacea Innovation Limited 3.55M 19.40%
2025-09-26 Panacea Venture Healthcare Fund II, L.P. 3.55M 19.40%
2025-08-12 Foresite Capital Fund VI, L.P. 787.12K 5.10%
2025-07-23 Panacea Venture Healthcare Fund II, L.P. 2.05M 13.20%
2025-06-20 ETP BIOHEALTH III FUND , L.P. 300K 1.90%
2025-06-20 WEI-WU HE, Ph.D. 3.74M 23.80%
2025-06-20 HUIYING MEMORIAL FOUNDATION 407.64K 2.60%
2025-06-20 EMERGING TECHNOLOGY PARTNERS, LLC 1.1M 7.10%
2025-06-20 ETP Global Fund L.P. 753.23K 4.90%
2025-06-20 HE Family GRAT 100000.0 0.60%
2025-02-03 Quan Zhou 992.64K 6.40%
2025-02-03 IDG-Accel China Growth Fund III L.P. 915.85K 5.90%
2025-02-03 IDG-Accel China III Investors L.P. 915.85K 5.90%
2025-02-03 IDG-Accel China Growth Fund III Associates L.P. 915.85K 5.90%
2025-02-03 IDG-Accel China Growth Fund GP III Associates Ltd. 915.85K 5.90%
2025-02-03 Ho Chi Sing 915.85K 5.90%
2024-07-25 Venrock Healthcare Capital Partners III, L.P. 1.51M 9.99%
2024-07-25 VHCP Management III, LLC 1.51M 9.99%
2024-07-25 VHCP Co-Investment Holdings III, LLC 1.51M 9.99%
2024-07-25 Venrock Healthcare Capital Partners EG, L.P. 1.51M 9.99%
2024-07-25 Koh, Bong 1.51M 9.99%
2024-07-25 Shah, Nimish 1.51M 9.99%
2024-07-25 VHCP Management EG, LLC 1.51M 9.99%
2024-06-20 S          Foresite Capital Management VI, LLC (“FCM VI”) 1.31M 9.80%
2024-06-20 S          James Tananbaum (“Tananbaum”) 1.31M 9.80%
2024-06-20 S          Foresite Capital Fund VI, L.P. (“FCF VI”) 1.31M 9.80%
2023-04-10 Panacea Venture Healthcare Fund II GP Company, Ltd. 1.23M 9.20%
2023-04-10 Panacea Venture Healthcare Fund II, L.P. 1.23M 9.20%
2023-04-10 Panacea Innovation Limited 1.23M 9.20%
2023-04-10 James Huang 1.23M 9.20%
2022-02-14 Mitchell Blutt - 0.00%
2022-02-14 Consonance Capital Management LP - 0.00%
2022-02-14 Consonance Capman GP LLC - 0.00%
2021-02-17 Consonance Capital Opportunity Fund Management LP 2.18M 1.75%
2021-02-17 Consonance Capital Management LP 5.4M 4.36%
2021-02-17 Mitchell Blutt 7.58M 6.11%
2021-02-17 Consonance Capman GP LLC 7.58M 6.11%
2021-02-16 Consonance Capital Opportunity Fund Management LP 1.19M 2.04%
2021-02-16 Consonance Capman GP LLC 6.06M 9.99%
2021-02-16 Mitchell Blutt 6.06M 9.99%
2021-02-16 Consonance Capital Management LP 5.4M 4.36%
2021-02-12 Federated Hermes, Inc. 10.0 12.00%
2020-08-18 Spectrum Pharmaceuticals, Inc. 9.23M 7.50%
2020-08-18 Spectrum Pharmaceuticals Cayman, L.P. 4.65M 3.80%
2020-02-19 Wealth Strategy Holding Limited 10.68M 10.91%
2019-02-06 DAPENG LI 9.36M 9.66%
2018-11-14 Jianguang Li 10.2M 11.80%
2018-11-14 Snow Moon Limited 10.2M 11.80%
2018-11-14 Dongliang Lin 10.2M 11.80%
2018-11-14 Sparkle Byte Limited 10.2M 11.80%
2018-11-14 He Xie Ai Qi Investment Management (Beijing) Co., Ltd. 10.2M 11.80%
2018-11-14 Tianjin Jingran Management Center (Limited Partnership) 10.2M 11.80%
2018-11-14 Fei Yang 10.2M 11.80%
2018-10-11 WEALTH STRATEGY HOLDING LIMITED 10.12M 10.67%
2017-12-01 WEALTH STRATEGY HOLDING LIMITED 6.3M 9.60%
2016-03-21 ZHEJIANG KANGLAITE GROUP CO., LTD 2.06M 5.03%
2016-01-25 Sparkle Byte Limited 5.69M 13.60%
2016-01-25 Snow Moon Limited 5.69M 13.60%
2016-01-25 Tianjin Jingran Management Center (Limited Partnership) 5.69M 13.60%
2016-01-25 He Xie Ai Qi Investment Management (Beijing) Co., Ltd. 5.69M 13.60%
2016-01-25 Jianguang Li 5.69M 13.60%
2016-01-25 Dongliang Lin 5.69M 13.60%
2016-01-25 Suyang Zhang 5.69M 13.60%
2016-01-25 Fei Yang 5.69M 13.60%
2011-02-14 Seaside 88 Advisors, LLC - 0.00%
2011-02-14 Seaside 88, LP - 0.00%
2011-02-14 William J. Ritger - 0.00%
2011-02-14 Denis M. O’Donnell - 0.00%
2006-02-14 Joseph Edelman 313.73K 0.40%
2006-02-09 Domain Public Equity Partners, L.P. 3.91M 5.30%
2005-01-26 Joseph Edelman 2.81M 6.54%
2003-01-10 FMR Corp. 339.5K 1.55%
2003-01-10 Abigail P. Johnson 339.5K 1.55%
2003-01-10 Edward C. Johnson 3d 339.5K 1.55%
2002-02-14 Abigail P. Johnson 1.22M 6.70%
2002-02-14 Edward C. Johnson 3d 1.22M 6.70%
2002-02-14 FMR Corp. 1.22M 6.70%
2001-02-13 Edward C. Johnson 3d 1.19M 7.03%
2001-02-13 Abigail P. Johnson 1.19M 7.03%
2001-02-13 FMR Corp. 1.19M 7.03%
CASI Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2024-12-31 $2.83 15.34M $43.41M $13.47M $22.14M $52.09M
2023-12-31 $7.16 13.36M $95.66M $17.08M $21.24M $99.81M
2022-12-31 $1.79 13.65M $24.43M $47.11M $1.34M -$21.34M
2021-12-31 $8.00 13.61M $108.88M $38.7M $4.33M $74.51M
2020-12-31 $29.50 11.05M $325.83M $57.06M $3.2M $271.97M
2019-12-31 $30.90 9.59M $296.48M $53.62M $2.2M $245.06M
2018-12-31 $40.20 8.48M $340.7M $84.2M $1.5M $258M
2017-12-31 $32.50 6.15M $199.92M $43.49M $1.5M $157.93M
2016-12-31 $11.50 5.59M $64.25M $27.09M $1.49M $38.65M
2015-12-31 $9.60 3.24M $31.15M $5.13M $1.46M $27.48M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-09-30 $1.66 16.05M $26.64M $4.68M $18.86M $40.81M
2025-06-30 $1.18 15.51M $18.3M $6.74M $18.73M $30.29M
2025-03-31 $2.16 15.49M $33.46M $10.9M $18.49M $41.06M
2024-12-31 $2.83 15.49M $43.84M $13.47M $22.14M $52.52M
2024-09-30 $6.16 15.29M $94.21M $16.54M $19.12M $96.8M
2024-06-30 $5.40 13.52M $73M $9.53M $18.46M $81.94M
2024-03-31 $3.66 13.38M $48.98M $12.2M $18.59M $55.36M
2023-12-31 $7.16 13.38M $95.79M $17.08M $21.24M $99.95M
2023-09-30 $2.56 13.38M $34.25M $19.98M -$ $14.27M
2023-06-30 $2.50 13.34M $33.36M $16.92M -$ $16.45M
2023-03-31 $2.32 13.34M $30.95M $16.59M -$ $14.35M
2022-12-31 $1.79 13.46M $24.09M $47.11M $1.34M -$21.68M